Showing results (201-210 of 334) with videos related to

Sort By:
Pageof 34
The Science of the Total Environment|August 20, 2020
Proceed with caution: The need to raise the publication bar for microplastics researchJennifer F Provencher, Garth A Covernton, Rhiannon C Moore, et al.
British Journal of Cancer|June 21, 2007
Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastomaJ C Lindsey, M E Lusher, J A Anderton, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USAR Kulkarni, K P Ponder, A H James, et al.
The Science of the Total Environment|September 16, 2023
Development and testing of a prototype indicator-based tool for identification of potential problem areas for marine litter in Europe's seasCiarán J Murray, Bert van Bavel, Ahmet E Kideyş, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
APC and CTNNB1 mutations are rare in sporadic ependymomasOlabisi E Onilude, Meryl E Lusher, Janet C Lindsey, et al.
Animals : an Open Access Journal From MDPI|October 14, 2022
First Documented Uses of Caves along the Coast of Albania by Mediterranean Monk Seals (Monachus monachus, Hermann 1779): Ecological and Conservation InferencesLuigi Bundone, Gema Hernandez-Milian, Nexhip Hysolakoj, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 23, 2010
Fibrinolytic parameters in children with noncatheter thrombosis: a pilot studyO Alphan Kupesiz, Meera B Chitlur, Wendy Hollon, et al.
The Journal of Biological Chemistry|December 17, 2009
Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701HDennis J van de Wijngaart, Michel Molier, Scott J Lusher, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
Thrombosis and Haemostasis|January 1, 1996
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia BA D Shapiro, M V Ragni, J M Lusher, et al.
Pageof 34